Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Bremen
Clinical trial register · Germany

Clinical Trials in Bremen, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5060 matching records held by the registry are in this view. Synced 14 Oct 2026, 03:18 UTC
5060
Studies in scope
all four open statuses
2879
Recruiting now
open to new participants
987
Lead sponsors
across recruiting studies
Top sites
Berlin 1589 Hamburg 891 Essen 764 Dresden 713 Heidelberg 627
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca5 Stichting Hemato-Oncologie voor Volwassenen Nederland4 Abbott Medical Devices3 Eli Lilly and Company3 Universitätsklinikum Hamburg-Eppendorf3
Site location
Berlin1589 Hamburg891 Essen764 Dresden713 Heidelberg627
All 640 locations
Target enrolment
to

Trials with a site in Bremen

92 of 5060 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Not yet open
ESR1Real World Assessment Prevalence Study
NCT07817212HR+/HER2- aBC Undergoing 1L Treatment With CDK4/6i (Palbociclib, Abemaciclib or Ribociclib) and AI (Anastrozole or Letrozole)
Institut fuer Frauengesundheit
Not applicable
1,550
Ansbach, Bremen, Celle, Dresden, Düsseldorf, Erlangen, Homburg, Ilsede
2026-10-01
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Bad Oldesloe, Bamberg, Berlin, Bielefeld, Bochum, Bremen, Chemnitz, Cologne
2026-08-24
Recruiting
Registry for Duchenne and Becker Muscular Dystrophy
NCT07402122Duchenne Muscular Dystrophy (DMD), Becker Muscular Dystrophy, Dystrophinopathy Symptomatic Female Carrier
Dr. Andreas Ziegler
Observational
1,500
Berlin, Bochum, Bonn, Bremen, Dresden, Erlangen, Essen, Freiburg im Breisgau
2026-07-13
Not yet open
iVascular S.L.U.
Not applicable
160
Bremen, Cologne, Dortmund, Hamburg, Nuremberg
2026-05-31
Recruiting
Shift Workers' Health Behavior Action Program Across Europe
NCT07631767Night Shift Work, Obesity & Overweight, Circadian Misalignment
Wageningen University
Not applicable
400
Bremen, Bremerhaven
2026-05-15
Recruiting
Eli Lilly and Company
Phase 2
600
Bergisch Gladbach, Berlin, Bielefeld, Bochum, Bonn, Bottrop, Bremen, Cottbus
2026-05-13
Recruiting
UNICANCER
Phase 3
3,902
Aachen, Augsburg, Bad Nauheim, Berlin, Bremen, Cottbus, Dresden, Düsseldorf
2025-12-18
Recruiting
Ipsen
Observational
150
Aschaffenburg, Berlin, Bonn, Bremen, Chemnitz, Cologne, Dresden, Erlangen
2025-12-17
Recruiting
Safety and Performance of a Pelvic Floor Mesh Implant (LatGYNious)
NCT07066761Pelvic Organ Prolapse (POP), Genital Prolapse, Uterus Prolapse, Laparoscopic Surgery
A.M.I. Agency for Medical Innovations GmbH
Not applicable
85
Brandenburg, Bremen, Tettnang
2025-11-01
Recruiting
BioNTech SE
Phase 3
558
Augsburg, Bremen, Frankfurt, Freiburg im Breisgau, Gera, Hamburg, Koblenz, Mannheim
2025-10-30
Recruiting
A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy
NCT07785180Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Stemline Therapeutics, Inc.
Observational
140
Bremen, Chemnitz, Leipzig, Lübeck, Munich, Oldenburg, Würzburg
2025-10-17
Recruiting
Herzzentrum Bremen
Not applicable
200
Bremen
2025-10-01
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Aachen, Ahaus, Altenburg, Bad Homburg, Berlin, Brandenburg an der Havel, Bremen, Cologne
2025-09-22
Active, closed
Hoffmann-La Roche
Phase 3
1,101
Aachen, Bad Homburg, Bayreuth, Bochum, Bremen, Erbach/Odenwald, Freiburg im Breisgau, Hamburg
2025-09-17
Active, closed
A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases
NCT06806592Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
DrugNerandomilast
Boehringer Ingelheim
Phase 3
413
Berlin, Bonn, Braunschweig, Bremen, Cologne, Düsseldorf, Essen, Freiburg im Breisgau
2025-09-13
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
Berlin, Bochum, Bonn, Braunschweig, Bremen, Darmstadt, Flensburg, Freiburg im Breisgau
2025-08-05
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Bad Homburg, Bad Krozingen, Bad Oeynhausen, Berlin, Bochum, Bremen, Bruchsal, Coburg
2025-07-22
Recruiting
Bristol-Myers Squibb
Phase 3
586
Mannheim, Münster, Mainz, Berlin, Aachen, Bremen, Hamburg, Munich
2025-07-14
Not yet open
Empowering Healthy Lifestyle Personalised Intervention to Prevent and Control Obesity: The HealthyW8 Project
NCT07011368Obesity Prevention, Obesity and Overweight, Obesity and Obesity-related Medical Conditions, Digital Health
Fundació d'investigació Sanitària de les Illes Balears
Not applicable
2,720
Bremen, Kaiserslautern
2025-07-01
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Berlin, Bochum, Bonn, Braunschweig, Bremen, Darmstadt, Essen, Flensburg
2025-05-05
Active, closed
Health Surveillance at Constructor University Bremen (CUB)
NCT06899308Social Isolation or Loneliness, Anxiety, Anxiety Depression (Mild or Not Persistent), Health Behavior
Jacobs University Bremen gGmbH
Observational
373
Bremen
2025-03-17
Recruiting
GBG Forschungs GmbH
Phase 2
120
Augsburg, Berlin, Bielefeld, Bremen, Cologne, Cottbus, Dortmund, Essen
2024-12-04
By invitation
Gymna Uniphy
Not applicable
74
Bremen
2024-10-29
Recruiting
Goethe University
Phase 2
28
Augsburg, Berlin, Bremen, Dresden, Düsseldorf, Erlangen, Frankfurt am Main, Hamburg
2024-10-22
Recruiting
University Hospital Schleswig-Holstein
Phase 2/3
459
Kiel, Aachen, Augsburg, Bamberg, Berlin, Bremen, Cologne, Dachau
2024-09-12
By invitation
B-challenged: Co-creating Physical and Social Environments to Promote Children's Active Outdoor Play
NCT07136376Active Outdoor Play and Related Healthy Dietary Behaviours
Amsterdam UMC, location VUmc
Not applicable
850
Bremen
2024-09-01
Recruiting
Abbott Structural Heart Device Registry
NCT06590467Heart Diseases, ASD - Atrial Septal Defect, VSD - Muscular Ventricular Septal Defect, PFO - Patent Foramen Ovale
Abbott Medical Devices
Observational
2,500
München, Bremen, Jena, Braunschweig, Berlin, Bad Rothenfelde
2024-08-21
Recruiting
Sanofi
Phase 3
160
Berlin, Bochum, Bremen, Essen, Göttingen, Hanover, Homburg, Münster
2024-08-21
Recruiting
AstraZeneca
Observational
600
Bad Homburg, Berlin, Bremen, Celle, Chemnitz, Cologne, Deggendorf, Frankfurt
2024-06-28
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Bad Berka, Berlin, Bielefeld, Bremen, Cologne, Dachau, Dortmund, Dresden
2024-06-25
Active, closed
Novartis Pharmaceuticals
Observational
116
Hamburg, Lingen, Koblenz, Leipzig, Halle, Ahaus, Berlin, Bremen
2024-06-11
Active, closed
The Lymphoma Academic Research Organisation
Phase 3
790
Amberg, Bamberg, Berlin, Bremen, Chemnitz, Düsseldorf, Frankfurt, Freiburg im Breisgau
2024-06-07
Recruiting
Immunocore Ltd
Phase 3
680
Berlin, Bremen, Dortmund, Dresden, Erfurt, Erlangen, Essen, Frankfurt
2024-06-05
Recruiting
Corheart 6 LVAS Study
NCT05876000Refractory Heart Failure
Shenzhen Core Medical Technology CO.,LTD.
Not applicable
53
Bad Oeynhausen, Berlin, Bremen, Hamburg, Heidelberg, Leipzig, Würzburg
2024-05-14
Active, closed
Eli Lilly and Company
Phase 3
10,000
Bad Nauheim, Bad Oeynhausen, Berlin, Bremen, Dortmund, Dresden, Elsterwerda, Essen
2024-04-30
Active, closed
Novo Nordisk A/S
Phase 3
673
Bremen, Dresden, Elsterwerda, Erfurt, Frankfurt, Freiburg im Breisgau, Fulda, Homburg
2024-04-01
Recruiting
AstraZeneca
Phase 3
5,250
Ahrensburg, Augsburg, Bamberg, Berlin, Bonn, Bremen, Cottbus, Dachau
2024-02-21
Recruiting
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
120
Berlin, Bremen, Dortmund, Friedrichshafen, Gerlingen, Gütersloh, Hamburg, Mainz
2024-01-17
Recruiting
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
NCT05512364ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer, Stage III Breast Cancer
DrugsElacestrant·Tamoxifen·Exemestane·Anastrozole
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
220
Aachen, Augsburg, Bergisch Gladbach, Bottrop, Bremen, Cologne, Dresden, Hanover
2023-12-15
Recruiting
CeraFlex PFO Closure System PMCF Study
NCT06120270Patent Foramen Ovale
Lifetech Scientific (Shenzhen) Co., Ltd.
Observational
180
Bremen, Dresden, Fürth, Hamburg, Leipzig, Munich, Trier, Tübingen
2023-11-03
Recruiting
Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI
NCT05786131Non-ST-elevation Myocardial Infarction, Multivessel Coronary Artery Disease
Leipzig Heart Science gGmbH
Not applicable
3,390
Bad Berka, Bad Krozingen, Bad Nauheim, Bad Oeynhausen, Berlin, Bielefeld, Bochum, Bremen
2023-10-27
Active, closed
Enlighten Study: The EV-ICD Post Approval Registry
NCT06048731Ventricular Arrhythmia, Tachycardia
Medtronic
Observational
1,000
Bad Oeynhausen, Bremen, Hanover, Stuttgart, Tübingen
2023-09-01
Active, closed
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
32
Amberg, Bad Saarow, Berlin, Brandenburg an der Havel, Bremen, Darmstadt, Essen, Frankfurt
2023-08-28
Recruiting
NovoCure Ltd.
Observational
198
Gauting, Regensburg, Harburg, Bremen, Göttingen, Dresden, Berlin, Cologne
2023-08-01
Recruiting
Improving Low ASPECTS Stroke Thrombectomy
NCT04862507Acute Ischemic Stroke
Universitätsklinikum Hamburg-Eppendorf
Observational
500
Berlin, Bremen, Hamburg, Kaiserslautern, Marburg, Münster, Rostock
2023-05-01
Active, closed
Real-world Clinical Outcomes of the MITRIS RESILIA Mitral Valve
NCT05526560Mitral Stenosis, Mitral Valve Insufficiency
Edwards Lifesciences
Observational
504
Augsburg, Bad Neustadt an der Saale, Bad Oeynhausen, Bonn, Bremen, München
2023-01-11
Recruiting
Greenwich LifeSciences, Inc.
Phase 3
2,250
Augsburg, Bayreuth, Berlin, Bottrop, Braunschweig, Bremen, Chemnitz, Dessau
2022-12-16
Active, closed
Amgen
Phase 3
7,297
Aachen, Bad Krozingen, Bad Oeynhausen, Berlin, Bremen, Cologne, Dresden, Essen
2022-12-14
Recruiting
Gilead Sciences
Phase 3
1,514
Augsburg, Berlin, Bielefeld, Bottrop, Braunschweig, Bremen, Cologne, Dortmund
2022-12-12
Recruiting
University of Ulm
Phase 3
650
Aschaffenburg, Bad Saarow, Berlin, Bochum, Bonn, Braunschweig, Bremen, Darmstadt
2022-09-13
Recruiting
AGO Study Group
Phase 3
970
Amberg, Augsburg, Bad Homburg, Berlin, Bielefeld, Brandenburg an der Havel, Bremen, Chemnitz
2022-09-13
Recruiting
German CLL Study Group
Phase 3
202
Bad Saarow, Berlin, Bremen, Cologne, Dortmund, Düsseldorf, Eschweiler, Essen
2022-04-19
Active, closed
TRICuspid Intervention in Heart Failure Trial
NCT04634266Heart Failure Attributable to Severe Tricuspid Regurgitation
LMU Klinikum
Not applicable
360
Bad Oeynhausen, Berlin, Bernau, Bonn, Bremen, Cologne, Dortmund, Düsseldorf
2022-03-25
Active, closed
NewAmsterdam Pharma
Phase 3
9,541
Bad Homburg, Berlin, Bremen, Chemnitz, Dortmund, Dresden, Elsterwerda, Erfurt
2022-02-07
Active, closed
University Hospital, Basel, Switzerland
Not applicable
543
Aachen, Berlin, Bremen, Dresden, Erfurt, Frankfurt, Göttingen, Hamburg
2021-12-09
Recruiting
Dominik Paul Modest
Phase 3
507
Amberg, Bad Saarow, Bayreuth, Berlin, Bochum, Bonn, Bremen, Chemnitz
2021-12-06
Active, closed
Christian Buske
Phase 2
99
Berlin, Bremen, Dortmund, Dresden, Hamburg, Hanover, Landshut, Munich
2021-08-18
Recruiting
German Cardiac Arrest Registry
NCT05142124Out-of-hospital Cardiac Arrest
Leipzig Heart Science gGmbH
Observational
400
Berlin, Bad Friedrichshall, Bonn, Bremen, Cologne, Dresden, Düsseldorf, Essen
2021-07-21
Recruiting
Valved Graft PMCF Study
NCT04754217Aortic Valve Disease, Ascending Aorta Abnormality, Aortic Dissection
Abbott Medical Devices
Observational
260
Bad Oeynhausen, Berlin, Bremen, Hanover
2021-07-13
Active, closed
Helios Health Institute GmbH
Not applicable
250
Bremen, Dresden, Düsseldorf, Essen, Hamburg, Leipzig, Ludwigshafen, Lübeck
2021-07-05
Active, closed
The SELUTION DeNovo Study
NCT04859985Coronary Artery Disease
M.A. Med Alliance S.A.
Not applicable
3,326
Augsburg, Bad Krozingen, Berlin, Bremen, Bruchsal, Cologne, Dresden, Essen
2021-05-15
Active, closed
Eli Lilly and Company
Phase 3
101
Freiburg im Breisgau, Sankt Augustin, Sendenhorst, Berlin, Bremen, Hamburg
2021-04-13
Active, closed
German CLL Study Group
Phase 3
897
Augsburg, Berlin, Bremen, Cologne, Dortmund, Dresden, Düsseldorf, Eisenach
2021-03-01
Recruiting
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
NCT04761120Mitral Regurgitation, Tricuspid Regurgitation, Valvular Heart Disease
Abbott Medical Devices
Observational
550
Passau, Würzburg, Bremen, Dresden, Jena
2021-02-01
Active, closed
Daiichi Sankyo
Phase 3
1,600
Augsburg, Berlin, Bielefeld, Böblingen, Braunschweig, Bremen, Chemnitz, Cologne
2020-12-04
Active, closed
Pfizer
Observational
1,407
Bayreuth, Nuremberg, Cottbus, Goslar, Bonn, Bad Mergentheim, Berlin, Bremen
2020-10-27
Active, closed
Michael Hopp
Phase 4
34
München, Giessen, Offenbach, Berlin, Bremen, Hamburg, Hamm, Immenstadt im Allgäu
2020-09-11
Recruiting
Mats Heyman
Phase 3
6,430
Bielefeld, Bonn, Bremen, Hamburg, Krefeld, Mainz
2020-07-13
Active, closed
University of Leipzig
Not applicable
5,227
München, Nuremberg, Bremen, Leipzig, Berlin, Altenburg, Aschaffenburg, Augsburg
2020-07-07
Active, closed
Herzzentrum Bremen
Not applicable
864
Bremen
2020-05-01
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
777
Aschaffenburg, Bad Saarow, Berlin, Bochum, Bonn, Braunschweig, Bremen, Darmstadt
2019-12-20
Active, closed
Christian Buske
Phase 2
53
Bielefeld, Bremen, Halle, Mannheim, Mönchengladbach, Mutlangen, München, Münster
2019-09-11
Active, closed
University of Ulm
Phase 3
882
Aschaffenburg, Bad Saarow, Berlin, Bochum, Bonn, Braunschweig, Bremen, Darmstadt
2019-09-04
Recruiting
University Hospital Muenster
Phase 3
683
Aachen, Augsburg, Berlin, Bielefeld, Bonn, Braunschweig, Bremen, Chemnitz
2019-08-23
Active, closed
University of Jena
Phase 2
125
Aachen, Berlin, Bonn, Bremen, Chemnitz, Dresden, Erlangen, Essen
2019-08-19
Active, closed
Automatic PredICtion of Edema After Stroke
NCT04057690Stroke, Acute, Brain Edema
University Hospital Tuebingen
Observational
1,687
Berlin, Bonn, Bremen, Düsseldorf, Hamburg, Hanover, Heidelberg, Leipzig
2019-04-01
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
968
Bad Saarow, Berlin, Bochum, Bonn, Braunschweig, Bremen, Dortmund, Düsseldorf
2019-03-01
Recruiting
RECORDATI GROUP
Observational
95
Bremen
2019-01-15
Active, closed
AstraZeneca
Phase 3
895
Bergisch Gladbach, Bremen, Cologne, Duisburg, Freiburg im Breisgau, Heinsberg, Mettmann, Nuremberg
2018-10-31
Active, closed
University Hospital Tuebingen
Phase 3
1,065
Amberg, Augsburg, Bad Kreuznach, Bremen, Dresden, Düsseldorf, Erfurt, Esslingen am Neckar
2018-07-27
Active, closed
University Hospital Muenster
Phase 3
650
Aachen, Augsburg, Berg, Berlin, Bielefeld, Bonn, Braunschweig, Bremen
2017-08-03
By invitation
The CINCH-FMR Post-Market Registry: Percutaneous Repair in Functional Mitral Regurgitation
NCT05677568Functional Mitral Regurgitation, Mitral Regurgitation
Cardiac Dimensions, Inc.
Observational
250
Aachen, Ahaus, Berlin, Bremen, Darmstadt, Dresden, Frankfurt, Fritzlar
2017-06-24
Active, closed
University Hospital Schleswig-Holstein
Not applicable
2,324
Amberg, Aue, Bad Saarow, Bayreuth, Berlin, Bocholt, Bremen, Buchholz
2015-06-16
Recruiting
International HIT-MED Registry (I-HIT-MED)
NCT02417324Childhood Brain Tumor
Universitätsklinikum Hamburg-Eppendorf
Observational
500
Aachen, Augsburg, Berlin, Bielefeld, Braunschweig, Bremen, Chemnitz, Cologne
2015-01
Active, closed
Karyopharm Therapeutics Inc
Phase 2
244
Aachen, Bad Saarow, Berlin, Bremen, Cologne, Dresden, Halle, Hanover
2014-11
Active, closed
Universitätsklinikum Hamburg-Eppendorf
Phase 2/3
360
Aachen, Augsburg, Berlin, Bielefeld, Bonn, Braunschweig, Bremen, Chemnitz
2014-06
Recruiting
The European Paediatric Network for Haemophilia Management ( PedNet Registry)
NCT02979119Factor VIII Deficiency, Factor IX Deficiency
PedNet Haemophilia Research Foundation
Observational
4,000
Berlin, Bonn, Bremen, Frankfurt, Frankfurt am Main, Munich
2014-06
Active, closed
AstraZeneca
Phase 3
1,837
Aachen, Augsburg, Baden-Baden, Berlin, Bonn, Bottrop, Brandenburg, Bremen
2014-04-22
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Aachen, Arnsberg, Bad Oeynhausen, Berlin, Bielefeld, Bochum, Bremen, Cologne
2012-01
Recruiting
University of Giessen
Phase 2/3
210
Ansbach, Aschaffenburg, Bad Neustadt an der Saale, Berlin, Bremen, Celle, Cottbus, Darmstadt
2004-05
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
615
Bremen
1989-09
Recruiting
Medtronic
Observational
20,000
Aachen, Bad Oeynhausen, Bielefeld, Bremen, Cologne, Dresden, Düsseldorf, Essen
1983-01
Rows per page Showing 1–92 of 92
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 October 2026. https://priyalifescience.com/clinical-trials-germany/city/bremen

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,060 studies in total at the last sync on 14 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 92 of those studies with a site in Bremen.

How many clinical trials are recruiting in Bremen?

47 of the 92 studies on this page are recruiting new participants as of the 14 Oct 2026, 03:18 UTC sync. A further 3 have not yet opened recruitment, 39 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bremen), 92 studies
PhaseStudiesRecruitingShare
Phase 3392042.4%
Observational231625%
Not applicable17518.5%
Phase 2949.8%
Phase 2/3323.3%
Phase 4101.1%

Most active sponsors

Lead sponsors with the most studies (Bremen)
Lead sponsorStudiesRecruiting
AstraZeneca53
Stichting Hemato-Oncologie voor Volwassenen Nederland42
Abbott Medical Devices33
Eli Lilly and Company31
Medtronic32
Universitätsklinikum Hamburg-Eppendorf32
Boehringer Ingelheim21
Christian Buske20
European Organisation for Research and Treatment of Cancer - EORTC21
German CLL Study Group21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.